Oracle (ORCL) Form 144: Proposed sale of 40,000 common shares on NYSE

Oracle (ORCL) filed a Form 144 notice for a proposed sale of 40,000 common shares.

Accepted by SEC EDGAR 10/21/2025 - 02:40 PM EDT Learn about SEC filing dates

Rhea-AI Filing Summary

Oracle (ORCL) filed a Form 144 notice for a proposed sale of 40,000 common shares. The filing lists an aggregate market value of $11,065,506.10, with an approximate sale date of 10/21/2025 on the NYSE through Fidelity Brokerage Services LLC.

The shares to be sold were acquired via restricted stock vesting: 37,270 shares on 09/15/2025 and 2,730 shares on 09/19/2025. Shares outstanding are stated as 2,841,714,000. In the past three months, the person for whose account the sale is proposed sold 21,241 shares on 09/12/2025 for gross proceeds of $6,310,864.10.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does Oracle (ORCL) disclose in this Form 144?

A proposed sale of 40,000 Oracle common shares with an aggregate market value of $11,065,506.10, planned around 10/21/2025 on the NYSE.

How were the ORCL shares to be sold acquired?

Through restricted stock vesting: 37,270 shares on 09/15/2025 and 2,730 on 09/19/2025.

Which broker and exchange are listed for the proposed ORCL sale?

Broker: Fidelity Brokerage Services LLC; Exchange: NYSE.

What are Oracle’s stated shares outstanding in the filing?

The filing lists 2,841,714,000 shares outstanding.

Were there recent sales by the same ORCL affiliated person?

Yes. 21,241 shares were sold on 09/12/2025 for gross proceeds of $6,310,864.10.

What is the approximate sale date in the ORCL Form 144?

The approximate date of sale is 10/21/2025.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0002071873
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	ORACLE CORP
SEC File Number	001-35992
Address of Issuer	2300 ORACLE WAY AUSTIN TEXAS 78741
Phone	(737) 867-1000
Name of Person for Whose Account the Securities are To Be Sold	Magouyrk Clayton M.
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	40000	11065506.10	2841714000	10/21/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	09/15/2025	Restricted Stock Vesting	Issuer			37270	09/15/2025	Compensation
Common	09/19/2025	Restricted Stock Vesting	Issuer			2730	09/19/2025	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Clayton Magouyrk 2300 Oracle Way Austin TX 78741	Common	09/12/2025	21241	6310864.10

144: Remarks and Signature

Remarks
Date of Notice	10/21/2025
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Jennifer Ruchti, as a duly authorized representative of Fidelity Brokerage Services LLC, as attorney-in-fact for Clayton Magouyrk
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)